RNS Number : 5383S
Pantheon International PLC
06 November 2019
 

For immediate release

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than the United Kingdom or to professional investors in Finland and Sweden), Canada, Australia, Japan or the Republic of South Africa.

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 

1.

Details of person discharging managerial responsibilities/person closely associated with them

a)

Name

Mary Ann Sieghart  

2.

Reason for the notification

a)

Position / status

Director/PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pantheon International Plc

b)

LEI

2138001B3CE5S5PEE928

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary shares of 67 pence each

 


GB0004148507

b)

Nature of the transaction

Purchase of Ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£22.781999

1325

d)

Aggregated information

- Aggregated volume

- Price

 

 

Price(s)

Aggregated Volume(s)

Aggregated Total

£22.781999

1325

£30,186.15

 

 

e)

Date of the transaction

06 November 2019

f)

Place of the transaction

London Stock Exchange

06 November 2019

Enquiries:

Pantheon Ventures (UK) LLP

Andrew Lebus / Vicki Bradley

020 3356 1800


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFSMFMMFUSESF